Piramal Pharma, 543635, PPLPHARMA Share Price, Rating, Research, Analysis, Fundamental & Historical Data

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

18,766.02
N/A
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

22,634.04
N/A
2.42

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

-
-
3.89

EBITDA CAGR (%)

10 Years
5 Years
3 Years

-
-
-15.14

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-
-50.46

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1,024.14 813.29 25.93% 994.24 828.87 19.95% 846.43 746.47 13.39% 1,054.58 1,127.09 -6.43%
Expenses 898.61 786.02 14.32% 908.08 782.04 16.12% 829.84 812.59 2.12% 965.03 944.84 2.14%
EBITDA 125.53 27.27 360.32% 86.16 46.83 83.98% 16.59 -66.12 - 89.55 182.25 -50.86%
EBIDTM 12.26% 3.35% 8.67% 5.65% 1.96% -8.86% 8.49% 16.17%
Other Income 33.11 53.88 -38.55% 89.08 117.70 -24.32% 26.68 106.61 -74.97% 62.88 75.29 -16.48%
Interest 17.42 33.22 -47.56% 28.22 28.56 -1.19% 33.80 20.31 66.42% 33.78 19.64 72.00%
Depreciation 51.56 47.19 9.26% 50.83 47.11 7.90% 50.37 44.78 12.48% 53.01 51.38 3.17%
PBT 89.66 0.74 12,016.22% 96.19 81.90 17.45% -40.90 -24.60 - 65.64 186.52 -64.81%
Tax 15.32 3.16 384.81% 19.03 34.57 -44.95% -7.54 -7.48 - 23.94 35.08 -31.76%
PAT 74.34 -2.42 - 77.16 47.33 63.03% -33.36 -17.12 - 41.70 151.44 -72.46%
PATM 7.26% -0.30% 7.76% 5.71% -3.94% -2.29% 3.95% 13.44%
EPS 0.56 -0.02 - 0.58 0.36 61.11% -0.25 -0.13 - 0.32 1.14 -71.93%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 1,958.57 1,715.97 14.14% 1,911.38 1,720.01 11.13% 1,748.85 1,481.99 18.01% 2,163.58 2,131.36 1.51%
Expenses 1,690.20 1,628.64 3.78% 1,645.74 1,547.45 6.35% 1,616.53 1,464.91 10.35% 1,812.31 1,733.40 4.55%
EBITDA 268.37 87.33 207.31% 265.64 172.56 53.94% 132.32 17.08 674.71% 351.27 397.96 -11.73%
EBIDTM 13.70% 5.09% 13.90% 10.03% 7.57% 1.15% 16.24% 18.67%
Other Income 61.51 82.54 -25.48% 49.19 46.22 6.43% 38.31 71.85 -46.68% 24.50 78.14 -68.65%
Interest 105.88 94.65 11.86% 109.87 82.98 32.41% 118.52 62.30 90.24% 104.25 57.06 82.70%
Depreciation 186.32 164.43 13.31% 184.51 166.19 11.02% 173.61 161.66 7.39% 184.41 165.16 11.66%
PBT 5.41 -89.21 - 20.45 -37.35 - -121.50 -135.03 - 87.11 253.88 -65.69%
Tax 9.25 16.54 -44.07% 34.54 11.08 211.73% -8.53 -6.09 - 44.78 68.88 -34.99%
PAT -3.84 -105.75 - -14.09 -48.43 - -112.97 -128.94 - 42.33 185.00 -77.12%
PATM -0.20% -6.16% -0.74% -2.82% -6.46% -8.70% 1.96% 8.68%
EPS 0.08 -0.74 - 0.04 -0.31 - -0.81 -0.90 - 0.41 1.68 -75.60%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Description TTM Mar 23 Mar 22 Mar 21
Net Sales 3,919.39 3,443.22 3,340.42 2,938.81 Net Sales Growth 11.48% 3.08% 13.67% Cost Of Goods Sold 1,939.09 1,768.48 1,561.51 1,227.77 Gross Profit 1,980.30 1,674.74 1,778.91 1,711.04 GP Margin 50.53% 48.64% 53.25% 58.22% Total Expenditure 3,601.56 3,345.69 2,865.14 2,319.88 Power & Fuel Cost - 107.94 83.83 68.08 % Of Sales - 3.13% 2.51% 2.32% Employee Cost - 548.50 448.03 395.15 % Of Sales - 15.93% 13.41% 13.45% Manufacturing Exp. - 318.40 283.52 246.85 % Of Sales - 9.25% 8.49% 8.40% General & Admin Exp. - 310.59 261.25 209.20 % Of Sales - 9.02% 7.82% 7.12% Selling & Distn. Exp. - 230.60 182.88 135.62 % Of Sales - 6.70% 5.47% 4.61% Miscellaneous Exp. - 61.18 44.12 37.21 % Of Sales - 1.78% 1.32% 1.27% EBITDA 317.83 97.53 475.28 618.93 EBITDA Margin 8.11% 2.83% 14.23% 21.06% Other Income 211.75 341.07 224.79 197.97 Interest 113.22 115.87 57.29 4.71 Depreciation 205.77 192.08 165.37 143.64 PBT 210.59 130.65 477.41 668.55 Tax 50.75 54.19 94.79 115.28 Tax Rate 24.10% 43.81% 20.50% 16.79% PAT 159.84 69.50 367.54 571.50 PAT before Minority Interest 159.84 69.50 367.54 571.50 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin 4.08% 2.02% 11.00% 19.45% PAT Growth -10.82% -81.09% -35.69% EPS 1.21 0.53 2.78 4.32

Description TTM Mar 23 Mar 22 Mar 21
Net Sales 7,782.38 7,081.55 6,559.10 6,314.90 Net Sales Growth 10.40% 7.97% 3.87% Cost Of Goods Sold 2,779.33 2,703.30 2,451.26 2,059.11 Gross Profit 5,003.05 4,378.25 4,107.84 4,255.79 GP Margin 64.29% 61.83% 62.63% 67.39% Total Expenditure 6,764.78 6,453.31 5,609.44 4,886.94 Power & Fuel Cost - 207.81 163.56 136.70 % Of Sales - 2.93% 2.49% 2.16% Employee Cost - 1,896.35 1,588.83 1,467.74 % Of Sales - 26.78% 24.22% 23.24% Manufacturing Exp. - 674.10 589.03 544.09 % Of Sales - 9.52% 8.98% 8.62% General & Admin Exp. - 472.78 428.49 367.25 % Of Sales - 6.68% 6.53% 5.82% Selling & Distn. Exp. - 372.59 317.81 247.91 % Of Sales - 5.26% 4.85% 3.93% Miscellaneous Exp. - 126.38 70.46 64.14 % Of Sales - 1.78% 1.07% 1.02% EBITDA 1,017.60 628.24 949.66 1,427.96 EBITDA Margin 13.08% 8.87% 14.48% 22.61% Other Income 173.51 225.11 275.80 164.11 Interest 438.52 344.18 198.25 163.45 Depreciation 728.85 676.69 586.18 545.04 PBT -8.53 -167.52 441.03 883.58 Tax 80.04 66.31 109.02 114.02 Tax Rate -938.34% -38.00% 25.59% 12.64% PAT -88.57 -186.46 375.96 835.03 PAT before Minority Interest -88.57 -186.46 375.96 835.03 Minority Interest 0.00 0.00 0.00 0.00 PAT Margin -1.14% -2.63% 5.73% 13.22% PAT Growth 0.00% - -54.98% EPS -0.67 -1.41 2.84 6.31

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21
Shareholder's Funds 5,261.79 5,123.12 4,100.62 Share Capital 1,193.32 1,185.91 994.60 Total Reserves 4,068.47 3,937.21 3,105.92 Non-Current Liabilities 1,083.17 800.72 184.38 Secured Loans 592.34 477.12 0.00 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 274.43 143.85 6.59 Current Liabilities 1,951.29 1,655.39 1,566.96 Trade Payables 761.67 646.80 584.12 Other Current Liabilities 430.07 488.22 681.78 Short Term Borrowings 720.34 390.21 165.20 Short Term Provisions 39.21 130.16 135.86 Total Liabilities 8,296.25 7,579.23 5,851.96 Net Block 2,601.87 2,438.98 1,626.81 Gross Block 3,570.69 3,225.28 2,260.11 Accumulated Depreciation 968.82 786.30 633.30 Non Current Assets 5,947.57 5,400.24 3,989.17 Capital Work in Progress 416.57 405.16 121.00 Non Current Investment 1,646.87 1,592.52 1,591.52 Long Term Loans & Adv. 1,282.22 963.54 649.84 Other Non Current Assets 0.04 0.04 0.00 Current Assets 2,348.68 2,178.99 1,862.79 Current Investments 100.12 37.01 0.00 Inventories 818.61 535.51 420.88 Sundry Debtors 909.56 989.22 839.75 Cash & Bank 64.16 137.23 152.35 Other Current Assets 456.23 39.00 44.50 Short Term Loans & Adv. 427.25 441.02 405.31 Net Current Assets 397.39 523.60 295.83 Total Assets 8,296.25 7,579.23 5,851.96

Description Mar 23 Mar 22 Mar 21
Shareholder's Funds 6,773.50 6,696.60 5,605.00 Share Capital 1,193.32 1,185.91 994.60 Total Reserves 5,580.18 5,510.69 4,610.30 Non-Current Liabilities 3,812.00 2,902.58 2,560.38 Secured Loans 3,383.54 2,622.14 2,339.16 Unsecured Loans 0.00 0.00 0.00 Long Term Provisions 275.97 145.34 6.78 Current Liabilities 3,851.04 3,118.01 2,590.70 Trade Payables 1,192.71 1,026.35 917.94 Other Current Liabilities 1,305.30 1,242.76 1,140.63 Short Term Borrowings 1,302.29 658.76 360.52 Short Term Provisions 50.74 190.14 171.61 Total Liabilities 14,436.54 12,717.19 10,756.08 Net Block 7,468.60 6,879.18 6,105.49 Gross Block 10,877.85 9,510.49 8,173.25 Accumulated Depreciation 3,409.25 2,631.31 2,067.76 Non Current Assets 9,593.07 8,565.30 7,006.96 Capital Work in Progress 1,418.58 1,172.34 626.65 Non Current Investment 211.87 216.77 122.67 Long Term Loans & Adv. 493.98 296.97 152.11 Other Non Current Assets 0.04 0.04 0.04 Current Assets 4,843.47 4,151.89 3,749.12 Current Investments 427.11 50.40 0.00 Inventories 1,681.37 1,388.80 1,232.00 Sundry Debtors 1,799.34 1,785.28 1,574.94 Cash & Bank 307.56 328.99 405.62 Other Current Assets 628.09 93.66 141.01 Short Term Loans & Adv. 487.85 504.76 395.55 Net Current Assets 992.43 1,033.88 1,158.42 Total Assets 14,436.54 12,717.19 10,756.08

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Description Mar 23 Mar 22 Mar 21
Cash From Operating Activity 71.52 249.19 34.72 PBT 130.65 477.41 349.11 Adjustment 50.70 42.92 8.96 Changes in Working Capital -49.80 -168.48 -228.06 Cash after chg. in Working capital 131.55 351.85 130.01 Interest Paid 0.00 0.00 0.00 Tax Paid -60.03 -102.66 -95.29 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -435.05 -1,245.61 -4,382.89 Net Fixed Assets -356.82 -1,249.33 Net Investments -117.46 -38.01 Others 39.23 41.73 Cash from Financing Activity 290.12 896.40 4,494.16 Net Cash Inflow / Outflow -73.41 -100.02 145.99 Opening Cash & Equivalents 127.69 146.72 0.74 Closing Cash & Equivalent 54.28 127.69 146.73

Description Mar 23 Mar 22 Mar 21
Cash From Operating Activity 483.89 766.42 597.58 PBT -167.52 441.03 639.68 Adjustment 1,135.53 787.10 721.99 Changes in Working Capital -295.12 -292.29 -619.58 Cash after chg. in Working capital 672.89 935.84 742.09 Interest Paid 0.00 0.00 0.00 Tax Paid -189.00 -169.42 -144.51 Other Direct Exp. Paid 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 Cash From Investing Activity -1,338.78 -1,812.10 -4,479.93 Net Fixed Assets -356.82 -1,249.33 Net Investments -117.46 -38.01 Others -864.50 -524.76 Cash from Financing Activity 817.79 794.19 3,976.83 Net Cash Inflow / Outflow -37.10 -251.49 94.48 Opening Cash & Equivalents 85.18 261.97 151.95 Closing Cash & Equivalent 53.23 85.18 261.97

Financial Ratios

Standalone /

Consolidated

Description Mar 23 Mar 22 Mar 21
Book Value (Rs.) 43.06 42.19 41.23 ROA 0.88% 5.47% 9.77% ROE 1.34% 7.97% 13.94% ROCE 3.64% 9.86% 16.21% Fixed Asset Turnover 1.05 1.24 1.30 Receivable days 96.97 98.40 104.30 Inventory Days 69.15 51.45 52.27 Payable days 145.35 143.86 173.65 Cash Conversion Cycle 20.77 5.99 -17.08 Total Debt/Equity 0.31 0.23 0.04 Interest Cover 2.07 9.07 146.81

Description Mar 23 Mar 22 Mar 21
Book Value (Rs.) 55.44 55.15 56.35 ROA -1.37% 3.20% 7.76% ROE -2.77% 6.11% 14.90% ROCE 1.95% 7.10% 13.06% Fixed Asset Turnover 0.80 0.83 0.77 Receivable days 80.70 83.94 91.03 Inventory Days 69.11 65.47 71.21 Payable days 149.81 144.76 162.72 Cash Conversion Cycle 0.00 4.65 -0.47 Total Debt/Equity 0.81 0.60 0.52 Interest Cover 0.65 3.45 6.81

Top Investors:

ca alchemy investments

east bridge capital master fund i ltd

life insurance corporation of india

hdfc mutual fund - hdfc focused 30 fund

indiahold limited

icici prudential value discovery fund

college retirement equities fund - stock account

llp

investor education and protection fund (iepf)

Annual Reports:

FY 2023

FY 2022

News Update:

Piramal Pharma’s consumer products division forays into men's grooming segment
11th Apr 2024, 16:31 PM

The launch of BOHEM aligns with the company's long-standing desire to cater to the male grooming market
Read More
USFDA conducts PAI inspection at Piramal Pharma’s USA facility
24th Feb 2024, 15:09 PM

On conclusion of the inspection, a Form-483 was issued with 2 observations
Read More
Piramal Pharma - Quarterly Results
30th Jan 2024, 20:48 PM

Read More
Piramal Pharma’s division launches new concentration of Zinc Sulfate for Injection in U.S.
17th Jan 2024, 09:21 AM

The launch will enable PCC to further expand their existing Zinc Sulfate Injection product line and overall the generic injectables portfolio
Read More

Piramal Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543635 | NSE: PPLPHARMA

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update:

Piramal Pharma Ltd.

Pharmaceuticals & Drugs

BSE: 543635 | NSE: PPLPHARMA

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Consolidated Figures in Rs. Crores /

Annual Results

Standalone Figures in Rs. Crores /

Results Balance Sheet

Standalone Figures in Rs. Crores /

Cash Flow

Standalone Figures in Rs. Crores /

Financial Ratios

Standalone /

Top Investors:

Annual Reports:

News Update: